HK-based life sciences VC Delos Capital holds first close of Fund III at $300m

Hong Kong-based life sciences venture capital (VC) firm Delos Capital has reached the first closing of its Fund III at $300 million with support from investors across the US and Greater China.

Read more:


在 建立網站或網誌

向上 ↑

%d 位部落客按了讚: